Biotech · Private company · Houston, TX, US
Ridgeline Therapeutics, Inc.
Track this companyFree. Adds Ridgeline Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards4
- Cardiovascular Safety and Scalable Manufacturing for Investigational New Drug Filing of a Novel Oral Drug to Accelerate Musculoskeletal Recovery in Older AdultsFiscal year 2026 · $2.1MNIH RePORTER 1R44AG102216-01 · fetched Nov 12, 2026
- Preclinical validation of a novel adjunct small molecule drug to prevent muscle loss and enhance weight loss in older adultsFiscal year 2026 · $904.8KNIH RePORTER 5R44AG092210-02 · fetched Nov 12, 2026
- Preclinical validation of a novel adjunct small molecule drug to prevent muscle loss and enhance weight loss in older adultsFiscal year 2025 · $1.3MNIH RePORTER 1R44AG092210-01A1 · fetched Nov 12, 2026
- Preclinical Development of a Novel Therapeutic to Rejuvenate Aging Muscle Stem Cells and Enhance Muscle Strength and Function Post Hip FractureFiscal year 2024 · $236.5KNIH RePORTER 3U44AG074107-03S1 · fetched Nov 12, 2026